Plain-English translation of NCT06727370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether lung cancer itself — or the treatments used to fight it — can affect how people think, remember, and concentrate. Some cancer patients report changes in their mental sharpness after diagnosis and treatment, and this study aims to measure these changes carefully using specialized thinking and memory tests.
Many people with lung cancer notice they have trouble concentrating or remembering things, but doctors don't yet fully understand how common this is or what causes it. This study will help doctors recognize and better support patients experiencing these changes.
You likely qualify if…
You likely don't qualify if…
You would complete a comprehensive set of thinking and memory tests — similar to puzzles, word games, and recall exercises — that take a few hours to finish. These tests would be done during your first year after being diagnosed, helping doctors track whether your mental sharpness changes over time. The study involves about 200 people across the European Institute of Oncology.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Italy
Enrollment target
~200 participants
Started
January 2024
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gabriella Pravettoni
Istituto Europeo di Oncologia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.